INS and Insulin resistance: Insulin normally suppresses liver FMO3 expression via phosphoinositide 3-kinase; insulin resistance abrogates this suppression, increasing FMO3 expression and plasma TMAO, positioning TMAO as a liver insulin resistance marker (151).